These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8991025

  • 1. [Evaluation of an intervention on the prescription and biological surveillance of low-molecular weight heparins in medicine].
    Fiessinger JN, Chatellier G.
    Presse Med; 1996 Nov 23; 25(36):1777-80. PubMed ID: 8991025
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Current indications of low-molecular-weight heparins].
    Vignes S, Meyer G, Marjanovic Z, Farge-Bancel D.
    Ann Med Interne (Paris); 1997 Nov 23; 148(2):154-62. PubMed ID: 9238441
    [Abstract] [Full Text] [Related]

  • 6. [Low molecular weight heparin: favorable effect profile for prevention and therapy of venous thrombosis].
    Marbet GA.
    Ther Umsch; 1992 Dec 23; 49(12):843-9. PubMed ID: 1336627
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
    Fiessinger JN.
    Bull Acad Natl Med; 1997 May 23; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
    [Abstract] [Full Text] [Related]

  • 8. [Monitoring of low-molecular-weight heparins in pregnant women with inherited thrombophilic disorders].
    Paskaleva I, Karagiozova Zh, Doncheva E, Dineva D.
    Akush Ginekol (Sofiia); 2014 May 23; 53(2):3-10. PubMed ID: 25098102
    [Abstract] [Full Text] [Related]

  • 9. [Meta-analysis on randomized trials comparing the results of low-molecular weight heparins to those of fractioned heparins in the prevention of deep venous thrombosis].
    Daures JP, Schved JF, Momas I, Gril JC, Azoulay P, Gremy F.
    Rev Epidemiol Sante Publique; 1989 May 23; 37(4):363-9. PubMed ID: 2558404
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Low molecular weight heparins in everyday practice].
    Horellou MH, Samama M.
    J Mal Vasc; 1991 May 23; 16(2):179-83. PubMed ID: 1650391
    [Abstract] [Full Text] [Related]

  • 12. [Low molecular weight heparins].
    Drouet L.
    Presse Med; 1993 Dec 18; 22(40):2002-8. PubMed ID: 8127804
    [Abstract] [Full Text] [Related]

  • 13. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
    Brewer D.
    J Fam Pract; 1998 Sep 18; 47(3):185-92. PubMed ID: 9752370
    [Abstract] [Full Text] [Related]

  • 14. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF, Hull RD.
    Clin Chest Med; 1995 Jun 18; 16(2):281-94. PubMed ID: 7656540
    [Abstract] [Full Text] [Related]

  • 15. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
    Lopaciuk S, Bielska-Falda H, Noszczyk W, Bielawiec M, Witkiewicz W, Filipecki S, Michalak J, Ciesielski L, Mackiewicz Z, Czestochowska E, Zawilska K, Cencora A.
    Thromb Haemost; 1999 Jan 18; 81(1):26-31. PubMed ID: 9974369
    [Abstract] [Full Text] [Related]

  • 16. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Hirsh J, Crowther M.
    Thromb Haemost; 1997 Jul 18; 78(1):689-92. PubMed ID: 9198240
    [Abstract] [Full Text] [Related]

  • 17. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H.
    Thromb Haemost; 1996 Feb 18; 75(2):246-50. PubMed ID: 8815569
    [Abstract] [Full Text] [Related]

  • 18. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.
    Lensing AW, Prins MH, Davidson BL, Hirsh J.
    Arch Intern Med; 1995 Mar 27; 155(6):601-7. PubMed ID: 7887755
    [Abstract] [Full Text] [Related]

  • 19. [Practical use of low molecular weight heparins in angiology].
    Plettner JL.
    J Mal Vasc; 1991 Mar 27; 16(4):398-401. PubMed ID: 1665170
    [Abstract] [Full Text] [Related]

  • 20. [Prophylactic prescription of low-molecular-weight heparin in the non-surgical setting: impact of recommendations].
    Fagot JP, Flahault A, Fodil M, Kanfer A, Alamowitch S, Haymann JP, Lecomte I, Lioté H, Parrot A, Rossert J, Verdy E, Becker A.
    Presse Med; 2001 Feb 10; 30(5):203-8. PubMed ID: 12385051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.